Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 518.40
-18.05 (-3.36%)
At close: Mar 27, 2026
Sakar Healthcare Market Cap
Sakar Healthcare has a market cap or net worth of 11.53 billion as of March 27, 2026. Its market cap has increased by 94.70% in one year.
Market Cap
11.53B
Enterprise Value
12.38B
Revenue
2.31B
Ranking
n/a
PE Ratio
45.61
Stock Price
518.40
Market Cap Chart
Since October 11, 2017, Sakar Healthcare's market cap has increased from 560.11M to 11.53B, an increase of 1,959.31%. That is a compound annual growth rate of 42.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 11.53B | 26.69% |
| Dec 31, 2025 | 9.10B | 41.21% |
| Dec 31, 2024 | 6.45B | -15.35% |
| Dec 29, 2023 | 7.62B | 82.44% |
| Dec 30, 2022 | 4.18B | 49.95% |
| Dec 31, 2021 | 2.78B | 89.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 39.23B |
| Innova Captab | 38.42B |
| RPG Life Sciences | 30.84B |
| Orchid Pharma | 25.48B |
| Solara Active Pharma Sciences | 21.33B |
| Windlas Biotech | 16.12B |
| Indoco Remedies | 16.01B |
| Jagsonpal Pharmaceuticals | 12.37B |